Marty Makary’s Turbulent Tenure at FDA Comes to an End

Source: The Dispatch · Bias: Center Right

Summary

Brought in as an agency critic, the commissioner drew fire from drug developers and abortion foes.

Related Coverage

Daily Analysis

Read the full Parallax Pulse for May 14, 2026 — an AI-powered analysis of how Left and Right media covered the biggest stories this day.

More Headlines From May 14, 2026

Marty Makary’s Turbulent Tenure at FDA Comes to an End
The Dispatch

Marty Makary’s Turbulent Tenure at FDA Comes to an End

Center Right

Brought in as an agency critic, the commissioner drew fire from drug developers and abortion foes.